Overview

Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

Status:
Recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

Phase I / II multicentre, randomized and controlled clinical trial to evaluate the efficacy of treatment with hyperimmune plasma obtained from convalescent antibodies of COVID-19 infection.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Andalusian Network for Design and Translation of Advanced Therapies

Treatments:

Hydroxychloroquine
Interferon beta-1b
Interferon-beta
Interferons
Lopinavir
Ritonavir